Roche receives FDA 510(k) clearance for the first blood test in the U.S. measuring Lp(a) in molar units
Approximately one in five people worldwide has elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics Tina-quant® Lipoprotein (a) Gen.2 Molarity

